Trial Profile
A retrospective study investigating efficacy of Belatacept based immunosuppression in lung transplant recipients after calcineurin inhibitor failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 13 Oct 2016 New trial record